SGLT2 inhibitors: expanding their Empire beyond diabetes

Marcel H. A. Muskiet; Hiddo J. L. Heerspink; Daniël H. van Raalte

doi:10.1016/S2213-8587(20)30428-9

SGLT2 inhibitors: expanding their Empire beyond diabetes

Amsterdam UMC - University of Amsterdam
University of Groningen, University Medical Center Groningen
VU Vrije Universiteit
University of Groningen

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	59-61
Number of pages	3
Journal	The Lancet Diabetes and Endocrinology
Volume	9
Issue number	2
Early online date	2021
DOIs	https://doi.org/10.1016/S2213-8587(20)30428-9
Publication status	Published - Feb 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S2213-8587(20)30428-9

Cite this

@article{995bbf885fbc4d41b74f41ad4ac7d245,

title = "SGLT2 inhibitors: expanding their Empire beyond diabetes",

author = "Muskiet, \{Marcel H. A.\} and Heerspink, \{Hiddo J. L.\} and \{van Raalte\}, \{Dani{\"e}l H.\}",

year = "2021",

month = feb,

doi = "10.1016/S2213-8587(20)30428-9",

language = "English",

volume = "9",

pages = "59--61",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - SGLT2 inhibitors: expanding their Empire beyond diabetes

AU - Muskiet, Marcel H. A.

AU - Heerspink, Hiddo J. L.

AU - van Raalte, Daniël H.

PY - 2021/2

Y1 - 2021/2

UR - https://www.scopus.com/pages/publications/85099219100

U2 - 10.1016/S2213-8587(20)30428-9

DO - 10.1016/S2213-8587(20)30428-9

M3 - Comment/Letter to the editor

C2 - 33357504

SN - 2213-8587

VL - 9

SP - 59

EP - 61

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

IS - 2

ER -

SGLT2 inhibitors: expanding their Empire beyond diabetes

UN SDGs

Access to Document

Other files and links

Cite this